Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Searle's Cytotec

Executive Summary

The company is underwriting an Arthritis Foundation educational campaign to make the public aware of measures available to prevent and treat NSAID-induced ulcers. In a March 30 satellite teleconference to launch the campaign, the foundation presented a panel of experts to discuss NSAID-induced ulcers, as well as a survey of 1,000 doctors' observations on the incidence of NSAID-induced ulcers. Searle has agreed to give over $ 1 mil. in support of the program for the first year. The program is expected to be multi-million dollar project to continue over the course of several years.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel